The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients.
Home » Clinical Trials » Clinical Trial Results Database
Clinical Trial Results: Dilatrend [carvedilol]
Product Name: Dilatrend [carvedilol]
Date of Report: 12/19/2003
Phase: III
A multicenter randomized double-blind, controlled study to compare the effect on mortality and morbidity over 46–74 months of carvedilol (Dilatrend) (oral titrated administration of 6.25 mg bid to 25 mg bid, with a preceding dose of 3.125 mg bid) and metoprolol (oral titrated administration of 12.5 mg bid to 50 mg bid with a preceding dose of 5 mg bid) in patients with chronic heart failure (NYHA II-IV).
Product Name: Dilatrend [carvedilol]
Date of Report: 3/23/2006
Phase: IV
Tolerability of Carvedilol Therapy in Elderly Patients with Congestive Heart Failure: The COLA II Study
Product Name: Dilatrend [carvedilol]
Date of Report: 4/1/2006
Phase: III
An open label, randomized, active controlled, multicentre study to assess efficacy and safety of carvedilol versus metoprolol in patients with chronic stable angina pectoris.
Product Name: Dilatrend [carvedilol]
Date of Report: 4/16/2008
Phase: IV
Influence of carvedilol (Dilatrend) on physical fitness and quality of life: assessment by accelerometry (using Physilog) in patients with heart failure (CALL study)
